Key facts
- It has raised $4.5M; the latest was Early Stage VC ($4.5M) in Mar 2025.
- Notable investors include Y Combinator, Pioneer Fund, Scrum Ventures, ZAKA VC, Overwater Ventures — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Olio Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Olio Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Olio Labs
Developer of combination therapeutics designed to be effective and have fewer side effects. The company specializes in using artificial intelligence to develop therapeutics that consider various interacting proteins in the body rather than just targeting one or two, enabling patients to be cured effectively.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Employees
- 8
- Website
- oliolabs.co/
- Ownership
- Privately Held (backing)
Olio Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Olio Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Olio Labs in its N-PORT filings yet. We sweep new filings monthly.